These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34292841)

  • 1. The UK National Screening Committee's position on child-parent screening for familial hypercholesterolaemia.
    Wald DS; Neely D
    J Med Screen; 2021 Sep; 28(3):217-220. PubMed ID: 34292841
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethnic access to child-parent screening for familial hypercholesterolaemia.
    Wald DS; Bestwick JP
    Eur J Prev Cardiol; 2019 Aug; 26(12):1341-1342. PubMed ID: 30971125
    [No Abstract]   [Full Text] [Related]  

  • 3. Integration of child-parent screening and cascade testing for familial hypercholesterolaemia.
    Wald DS; Wald NJ
    J Med Screen; 2019 Jun; 26(2):71-75. PubMed ID: 30319009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation screening in patients for familial hypercholesterolaemia (ADH).
    Taylor A; Patel K; Tsedeke J; Humphries SE; Norbury G
    Clin Genet; 2010 Jan; 77(1):97-9. PubMed ID: 19843101
    [No Abstract]   [Full Text] [Related]  

  • 5. Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies.
    Wald DS; Bestwick JP
    Atherosclerosis; 2020 Jan; 293():57-61. PubMed ID: 31837509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal screening of children for familial hypercholesterolaemia: Value for money?
    Ademi Z; Martin AC
    Atherosclerosis; 2018 Aug; 275():384-386. PubMed ID: 29961599
    [No Abstract]   [Full Text] [Related]  

  • 7. Decision to reject screening for familial hypercholesterolaemia is flawed.
    Wald DS; Martin AC
    Arch Dis Child; 2021 Jun; 106(6):525-526. PubMed ID: 32601084
    [No Abstract]   [Full Text] [Related]  

  • 8. People at risk of familial hypercholesterolaemia should have DNA test, says NICE.
    BMJ; 2017 Nov; 359():j5112. PubMed ID: 29097374
    [No Abstract]   [Full Text] [Related]  

  • 9. Familial hypercholesterolaemia: Child-parent screening may have adverse psychological effects.
    Hopcroft KA
    BMJ; 2007 Oct; 335(7622):683. PubMed ID: 17916819
    [No Abstract]   [Full Text] [Related]  

  • 10. Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis.
    Warner M
    Ann Clin Biochem; 2008 Jan; 45(Pt 1):114. PubMed ID: 18275690
    [No Abstract]   [Full Text] [Related]  

  • 11. Parental attitude towards genetic testing for familial hypercholesterolaemia in children.
    Umans-Eckenhausen MA; Oort FJ; Ferenschild KC; Defesche JC; Kastelein JJ; de Haes JC
    J Med Genet; 2002 Sep; 39(9):e49. PubMed ID: 12205119
    [No Abstract]   [Full Text] [Related]  

  • 12. [Advantages of Universal Early Childhood Screening for Familial Hypercholesterolaemia in Germany].
    Paetow U; Kordonouri O; Schwab KO
    Klin Padiatr; 2023 Jan; 235(1):5-12. PubMed ID: 35240713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for familial hypercholesterolaemia. Effective, safe treatments and dna testing make screening attractive.
    Kastelein JJ
    BMJ; 2000 Dec; 321(7275):1483-4. PubMed ID: 11118161
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular testing for familial hypercholesterolaemia-associated mutations in a UK-based cohort: development of an NGS-based method and comparison with multiplex polymerase chain reaction and oligonucleotide arrays.
    Reiman A; Pandey S; Lloyd KL; Dyer N; Khan M; Crockard M; Latten MJ; Watson TL; Cree IA; Grammatopoulos DK
    Ann Clin Biochem; 2016 Nov; 53(6):654-662. PubMed ID: 26748104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parent-child genetic testing for familial hypercholesterolaemia in an Australian context.
    Pang J; Martin AC; Bates TR; Hooper AJ; Bell DA; Burnett JR; Norman R; Watts GF
    J Paediatr Child Health; 2018 Jul; 54(7):741-747. PubMed ID: 29626384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis.
    McKay AJ; Hogan H; Humphries SE; Marks D; Ray KK; Miners A
    Atherosclerosis; 2018 Aug; 275():434-443. PubMed ID: 29937236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes.
    Marks D; Thorogood M; Neil SM; Humphries SE; Neil HA
    J Med Screen; 2006; 13(3):156-9. PubMed ID: 17007658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
    Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
    Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hypercholesterolaemia.
    Vohnout B; Raslová K; Gasparovic J; Donati MB; Iacoviello L
    Lancet; 2001 May; 357(9269):1712. PubMed ID: 11428370
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic screening for familial hypercholesterolaemia in Hong Kong.
    Tan K; Cheung CL; Yeung CY; Siu D; Leung J; Pang HK
    Hong Kong Med J; 2018 Jun; 24 Suppl 3(3):7-10. PubMed ID: 29937437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.